文献速递肝病

磁共振弹性成像与瞬时弹性成像在活检证实的非酒精性脂肪性肝病患者中检测纤维化和无创测量脂肪变的比较

Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
PubMed 文献 · Gastroenterology · 2016-10-27

这项前瞻性横断面研究纳入104例连续成人非酒精性脂肪性肝病(NAFLD)患者,比较磁共振弹性成像(MRE)与瞬时弹性成像(TE)诊断纤维化、以及磁共振质子密度脂肪分数(MRI-PDFF)与TE受控衰减参数(CAP)诊断脂肪变的效能。结果显示MRE检测任何纤维化(分期≥1)的AUROC为0.82,显著高于TE的0.67;MRI-PDFF检测任何脂肪变的AUROC为0.99,显著高于CAP的0.85。

要点

  • MRE检测任何纤维化(分期≥1)的AUROC为0.82,显著高于TE的0.67。
  • MRI-PDFF检测任何脂肪变的AUROC为0.99,显著高于CAP的0.85。
  • MRI-PDFF检测2级和3级脂肪变的AUROC分别为0.90和0.92,均高于CAP的0.70和0.73。

核心结论

  • 在活检证实的NAFLD患者中,MRE检测肝纤维化(分期≥1)的准确性高于TE,MRI-PDFF检测各级脂肪变的准确性高于CAP。

研究设计与样本

  • 前瞻性横断面研究,纳入2011年10月至2016年5月在一家三级医疗中心连续接受MRE、TE和肝活检的104例成人(女性占56.7%)。

主要发现

  • MRE检测任何纤维化(分期≥1)的AUROC为0.82(95%CI 0.74-0.91),显著高于TE的0.67(95%CI 0.56-0.78)。
  • MRI-PDFF检测任何脂肪变的AUROC为0.99(95%CI 0.98-1.00),显著高于CAP的0.85(95%CI 0.75-0.96)。
  • MRE检测2、3、4期纤维化的AUROC分别为0.89(95%CI 0.83-0.96)、0.87(95%CI 0.78-0.96)、0.87(95%CI 0.71-1.00);TE对应的AUROC分别为0.86(95%CI 0.77-0.95)、0.80(95%CI 0.67-0.93)、0.69(95%CI 0.45-0.94)。
  • MRI-PDFF检测2级和3级脂肪变的AUROC分别为0.90(95%CI 0.82-0.97)和0.92(95%CI 0.84-0.99);CAP对应的AUROC分别为0.70(95%CI 0.58-0.82)和0.73(95%CI 0.58-0.89)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Magnetic resonance imaging (MRI) techniques and ultrasound-based transient elastography (TE) can be used in noninvasive diagnosis of fibrosis and steatosis in patients with nonalcoholic fatty liver disease (NAFLD). We performed a prospective study to compare the performance of magnetic resonance elastography (MRE) vs TE for diagnosis of fibrosis, and MRI-based proton density fat fraction (MRI-PDFF) analysis vs TE-based controlled attenuation parameter (CAP) for diagnosis of steatosis in patients undergoing biopsy to assess NAFLD. METHODS: We performed a cross-sectional study of 104 consecutive adults (56.7% female) who underwent MRE, TE, and liver biopsy analysis (using the histologic scoring system for NAFLD from the Nonalcoholic Steatohepatitis Clinical Research Network Scoring System) from October 2011 through May 2016 at a tertiary medical center. All patients received a standard clinical evaluation, including collection of history, anthropometric examination, and biochemical tests. The primary outcomes were fibrosis and steatosis. Secondary outcomes included dichotomized stages of fibrosis and nonalcoholic steatohepatitis vs no nonalcoholic steatohepatitis. Receiver operating characteristic curve analyses were used to compare performances of MRE vs TE in diagnosis of fibrosis (stages 1-4 vs 0) and MRI-PDFF vs CAP for diagnosis of steatosis (grades 1-3 vs 0) with respect to findings from biopsy analysis. RESULTS: MRE detected any fibrosis (stage 1 or more) with an area under the receiver operating characteristic curve (AUROC) of 0.82 (95% confidence interval [CI], 0.74-0.91), which was significantly higher than that of TE (AUROC, 0.67; 95% CI, 0.56-0.78). MRI-PDFF detected any steatosis with an AUROC of 0.99 (95% CI, 0.98-1.00), which was significantly higher than that of CAP (AUROC, 0.85; 95% CI, 0.75-0.96). MRE detected fibrosis of stages 2, 3, or 4 with AUROC values of 0.89 (95% CI, 0.83-0.96), 0.87 (95% CI, 0.78-0.96), and 0.87 (95% CI, 0.71-1.00); TE detected fibrosis of stages 2, 3, or 4 with AUROC values of 0.86 (95% CI, 0.77-0.95), 0.80 (95% CI, 0.67-0.93), and 0.69 (95% CI, 0.45-0.94). MRI-PDFF identified steatosis of grades 2 or 3 with AUROC values of 0.90 (95% CI, 0.82-0.97) and 0.92 (95% CI, 0.84-0.99); CAP identified steatosis of grades 2 or 3 with AUROC values of 0.70 (95% CI, 0.58-0.82) and 0.73 (95% CI, 0.58-0.89). CONCLUSIONS: In a prospective, cross-sectional study of more than 100 patients, we found MRE to be more accurate than TE in identification of liver fibrosis (stage 1 or more), using biopsy analysis as the standard. MRI-PDFF is more accurate than CAP in detecting all grades of steatosis in patients with NAFLD.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Park CC, Nguyen P, Hernandez C, et al. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease. Gastroenterology. 2016. PMID: 27911262. doi:10.1053/j.gastro.2016.10.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。